Details for New Drug Application (NDA): 018760
✉ Email this page to a colleague
The generic ingredient in TENORETIC 50 is atenolol; chlorthalidone. There are thirty-four drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.
Summary for 018760
Tradename: | TENORETIC 50 |
Applicant: | Twi Pharms |
Ingredient: | atenolol; chlorthalidone |
Patents: | 0 |
Pharmacology for NDA: 018760
Mechanism of Action | Adrenergic beta-Antagonists |
Physiological Effect | Increased Diuresis |
Suppliers and Packaging for NDA: 018760
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
TENORETIC 100 | atenolol; chlorthalidone | TABLET;ORAL | 018760 | NDA | TWi Pharmaceuticals, Inc. | 24979-256 | 24979-256-07 | 90 TABLET in 1 BOTTLE (24979-256-07) |
TENORETIC 100 | atenolol; chlorthalidone | TABLET;ORAL | 018760 | NDA | TWi Pharmaceuticals, Inc. | 24979-257 | 24979-257-07 | 90 TABLET in 1 BOTTLE (24979-257-07) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 100MG;25MG | ||||
Approval Date: | Jun 8, 1984 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 50MG;25MG | ||||
Approval Date: | Jun 8, 1984 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 018760
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Twi Pharms | TENORETIC 50 | atenolol; chlorthalidone | TABLET;ORAL | 018760-002 | Jun 8, 1984 | ⤷ Subscribe | ⤷ Subscribe |
Twi Pharms | TENORETIC 100 | atenolol; chlorthalidone | TABLET;ORAL | 018760-001 | Jun 8, 1984 | ⤷ Subscribe | ⤷ Subscribe |
Twi Pharms | TENORETIC 50 | atenolol; chlorthalidone | TABLET;ORAL | 018760-002 | Jun 8, 1984 | ⤷ Subscribe | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription